Personalis, Inc.
PSNLNASDAQHealthcare● Active
$10.04
$-0.71(-6.60%)
Market Cap$891595654
P/E Ratio—
52W High$11.85
52W Low$3.84
Personalis, Inc. (PSNL) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
PSNL · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 7, 2026EPS Actual
-$0.29
Est. -$0.23 · -26.1%
Revenue
$0.02B
Est. $0.01B · +6.8%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 7, 2026
After Market Close
▼ Miss EPS▲ Beat Revenue
PSNL reports quarterly as a NASDAQ-listed Medical - Diagnostics & Research company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 4, 2026 | -$0.25 | — | — | — | $0.02B | — |
| ▼ Q2 FY2026 | May 7, 2026 | -$0.23 | -$0.29 | -26.1% | $0.02B | $0.01B | +6.8% |
| ▲ Q1 FY2026 | Feb 26, 2026 | -$0.31 | -$0.26 | +16.1% | $0.02B | $0.02B | +1.7% |
| ▲ Q4 FY2025 | Nov 4, 2025 | -$0.28 | -$0.24 | +14.3% | $0.01B | $0.02B | -14.9% |
| ▲ Q3 FY2025 | Aug 5, 2025 | -$0.25 | -$0.23 | +8.0% | $0.02B | $0.02B | -14.5% |
| ▲ Q2 FY2025 | May 6, 2025 | -$0.23 | -$0.18 | +21.7% | $0.02B | $0.02B | +18.3% |
| ▲ Q1 FY2025 | Feb 27, 2025 | -$0.32 | -$0.23 | +28.1% | $0.02B | $0.02B | +8.6% |
| ▼ Q4 FY2024 | Nov 6, 2024 | -$0.33 | -$0.64 | -93.9% | $0.03B | $0.02B | +65.5% |
Q3 FY2026
Aug 4, 2026
EPS Actual
—
EPS Est.
-$0.25
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 7, 2026Miss
EPS Actual
-$0.29
EPS Est.
-$0.23
EPS Surpr.
-26.1%
Revenue
$0.02B
Q1 FY2026
Feb 26, 2026Beat
EPS Actual
-$0.26
EPS Est.
-$0.31
EPS Surpr.
+16.1%
Revenue
$0.02B
Q4 FY2025
Nov 4, 2025Beat
EPS Actual
-$0.24
EPS Est.
-$0.28
EPS Surpr.
+14.3%
Revenue
$0.01B
Q3 FY2025
Aug 5, 2025Beat
EPS Actual
-$0.23
EPS Est.
-$0.25
EPS Surpr.
+8.0%
Revenue
$0.02B
Q2 FY2025
May 6, 2025Beat
EPS Actual
-$0.18
EPS Est.
-$0.23
EPS Surpr.
+21.7%
Revenue
$0.02B
Q1 FY2025
Feb 27, 2025Beat
EPS Actual
-$0.23
EPS Est.
-$0.32
EPS Surpr.
+28.1%
Revenue
$0.02B
Q4 FY2024
Nov 6, 2024Miss
EPS Actual
-$0.64
EPS Est.
-$0.33
EPS Surpr.
-93.9%
Revenue
$0.03B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $-0.21 | $-0.20 | $-0.19 | 1 |
| Q3 FY2027 | $-0.21 | $-0.21 | $-0.20 | 1 |
| Q2 FY2027 | $-0.23 | $-0.22 | $-0.21 | 1 |
| Q1 FY2027 | $-0.27 | $-0.26 | $-0.25 | 1 |
| Q4 FY2026 | $-0.24 | $-0.23 | $-0.22 | 1 |
| Q3 FY2026 | $-0.25 | $-0.24 | $-0.23 | 3 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 3 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 2 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 2 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 3 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 3 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 4 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 7, 2026 | -26.1% | $6.07 | $5.99 | -1.32% |
| ▲ Q1 FY2026 | Feb 26, 2026 | +16.1% | $8.31 | $9.03 | +8.66% |
| ▲ Q4 FY2025 | Nov 4, 2025 | +14.3% | $9.00 | $8.73 | -3.00% |
| ▲ Q3 FY2025 | Aug 5, 2025 | +8.0% | $5.57 | $5.64 | +1.26% |
| ▲ Q2 FY2025 | May 6, 2025 | +21.7% | $4.26 | $4.00 | -6.10% |
| ▲ Q1 FY2025 | Feb 27, 2025 | +28.1% | $4.48 | $4.24 | -5.36% |
| ▼ Q4 FY2024 | Nov 6, 2024 | -93.9% | $5.64 | $5.58 | -1.06% |
| ▲ Q3 FY2024 | Aug 7, 2024 | +29.4% | $3.20 | $2.88 | -10.00% |
Q2 FY2026-1.32%
Report Date
May 7, 2026
EPS Beat/Miss
-26.1%
Price Before
$6.07
Price After
$5.99
Q1 FY2026+8.66%
Report Date
Feb 26, 2026
EPS Beat/Miss
+16.1%
Price Before
$8.31
Price After
$9.03
Q4 FY2025-3.00%
Report Date
Nov 4, 2025
EPS Beat/Miss
+14.3%
Price Before
$9.00
Price After
$8.73
Q3 FY2025+1.26%
Report Date
Aug 5, 2025
EPS Beat/Miss
+8.0%
Price Before
$5.57
Price After
$5.64
Q2 FY2025-6.10%
Report Date
May 6, 2025
EPS Beat/Miss
+21.7%
Price Before
$4.26
Price After
$4.00
Q1 FY2025-5.36%
Report Date
Feb 27, 2025
EPS Beat/Miss
+28.1%
Price Before
$4.48
Price After
$4.24
Q4 FY2024-1.06%
Report Date
Nov 6, 2024
EPS Beat/Miss
-93.9%
Price Before
$5.64
Price After
$5.58
Q3 FY2024-10.00%
Report Date
Aug 7, 2024
EPS Beat/Miss
+29.4%
Price Before
$3.20
Price After
$2.88
Avg Beat Reaction-2.42%
Avg Miss Reaction-1.19%
Beat Rate6 / 8 quarters
Largest Move-10.00% (Q3 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: PSNL ends December
Personalis, Inc. (PSNL) most recently reported earnings on May 7, 2026 for Q2 FY2026, posting EPS of $-0.29 — missing the analyst consensus of $-0.23 by -26.1%. The next PSNL earnings date is expected around September 1, 2026.
Each quarter, investors track PSNL earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. PSNL revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
PSNL's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
PSNL earnings · 5 questionsPersonalis, Inc.'s next earnings report is expected around September 1, 2026. PSNL typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; PSNL historically reports after market close (AMC).
PSNL earnings datewhen is PSNL earningsPSNL next earnings datewhen does PSNL report earningsPSNL earnings calendar
▸ Source: FMP · Personalis, Inc. SEC filings · US GAAP · Personalis, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026